Pyrazinamide-isoniazid hybrid: synthesis optimisation, characterisation, and antituberculous activity

被引：1

作者：

Panti, Rocio I. Ramirez ^{[1
]}

Paucar, Christian M. Aliaga ^{[1
]}

Arias, Fernando Grandez ^{[1
]}

Cortovaria, Patricia Sheen ^{[2
]}

Peralta, Mirko Juan Zimic ^{[2
]}

Orocollo, Yudith Cauna ^{[2
]}

Negron, Ana C. Valderrama ^{[1
]}

机构：

[1] Univ Nacl Ingn, Biopolymer & Met Pharmaceut Res Lab LIBIPMET, Fac Sci, Lima, Peru

[2] Univ Peruana Cayetano Heredia, Bioinformat & Mol Biol Lab, Fac Sci & Philosophy, Lima, Peru

来源：

REVISTA COLOMBIANA DE QUIMICA | 2021年 / 50卷 / 03期

关键词：

tuberculosis TEMA; MIC; ultrasound; isoniazid; pyrazinamide; IN-VITRO; MYCOBACTERIUM; DERIVATIVES; DESIGN; ANTIMYCOBACTERIAL; SUSCEPTIBILITY; COMPLEXES; ASSAY; ACID;

D O I：

10.15446/rev.colomb.quim.v50n3.96424

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

Over time, the effective resistance mechanisms to various first- and second-line drugs against the disease of tuberculosis make its treatment extremely difficult. This work presents a new approach to synthesizing a hybrid of antituberculosis medications: isoniazid (INH) and pyrazinamide (PZA). The synthesis was performed using ultrasound-assisted synthesis to obtain an overall yield of 70%, minimizing the reaction time from 7 to 1 h. The evaluation of the biological activity of the hybrid (compound 2) was tested using the tetrazolium microplate assay (TEMA), showing inhibition in the growth of Mycobacterium tuberculosis H(37)Rv at a concentration of 0.025 mM at pH 6.0 and 6.7.

引用

页码：16 / 23

页数：8

共 50 条

[21] Synthesis and antituberculous activity of the polymeric forms of isoniazid and streptomycin based on carboxymethyldextran esters
Slivkin A.I.
Sirotkina G.G.
Lapenko V.L.
Pharmaceutical Chemistry Journal, 1999, 33 (12) : 661 - 664
[22] SIDE EFFECTS OF AN ANTITUBERCULOUS 5-DRUG REGIMEN - ETHIONAMIDE, CYCLOSERINE, PYRAZINAMIDE, VIOMYCIN AND ISONIAZID
TANI, P
POPPIUS
ACTA TUBERCULOSEA ET PNEUMOLOGICA SCANDINAVICA, 1963, 43 (03): : 256 - &
[23] PYRAZINAMIDE-ISONIAZID IN TUBERCULOSIS .2. RESULTS IN 58 PATIENTS WITH PULMONARY LESIONS ONE YEAR AFTER THE START OF THERAPY
MUSCHENHEIM, C
MCDERMOTT, W
MCCUNE, R
DEUSCHLE, K
ORMOND, L
TOMPSETT, R
AMERICAN REVIEW OF TUBERCULOSIS, 1954, 70 (04): : 743 - 747
[24] ANTITUBERCULOUS ACTIVITY OF HINCONSTARCH, A SYNTHETIC POLYMER OF ISONIAZID, AMITHIOZONE, AND STARCH
WOLINSKY, E
STEENKEN, W
AMERICAN REVIEW OF TUBERCULOSIS AND PULMONARY DISEASES, 1956, 73 (01): : 72 - 78
[25] SYNTHESIS OF SULFONES WITH ANTITUBERCULOUS ACTIVITY
MERCHANT, JR
GUPTA, AS
SHAH, PJ
SHIRALI, SS
CHEMISTRY & INDUSTRY, 1979, (10) : 351 - 352
[26] SYNTHESIS OF HYDRAZONES WITH ANTITUBERCULOUS ACTIVITY
MOKHTAR, HM
PHARMAZIE, 1979, 34 (03): : 150 - 152
[27] DELETERIOUS INFLUENCE OF PYRAZINAMIDE ON THE OUTCOME OF PATIENTS WITH FULMINANT OR SUBFULMINANT LIVER-FAILURE DURING ANTITUBERCULOUS TREATMENT INCLUDING ISONIAZID
DURAND, F
BERNUAU, J
PESSAYRE, D
SAMUEL, D
BELAICHE, J
DEGOTT, C
BISMUTH, H
BELGHITI, J
ERLINGER, S
RUEFF, B
BENHAMOU, JP
HEPATOLOGY, 1995, 21 (04) : 929 - 932
[28] PYRAZINAMIDE INCREASES MORTALITY IN PATIENTS PRESENTING FULMINANT OR SUBFULMINANT LIVER-FAILURE DURING ANTITUBERCULOUS TREATMENT INCLUDING ISONIAZID
DURAND, F
BERNUAU, J
PESSAYRE, D
SAMUEL, D
BELAICHE, J
BISMUTH, H
BELGHITI, J
ERLINGER, S
RUEFF, B
BENHAMOU, JP
HEPATOLOGY, 1992, 16 (02) : 531 - 531
[29] STERILIZING ACTIVITY OF ISONIAZID AND PYRAZINAMIDE IN COMBINATION WITH RIFAMPICIN IN THE EXPERIMENTAL TUBERCULOSIS OF THE MOUSE
GROSSET, J
TRUFFOT, C
BOVAL, C
FERMANIAN, J
REVUE FRANCAISE DES MALADIES RESPIRATOIRES, 1980, 8 (01): : 31 - 32
[30] STERILIZING ACTIVITY OF ISONIAZID AND PYRAZINAMIDE IN COMBINATION WITH RIFAMPICIN IN EXPERIMENTAL TUBERCULOSIS OF THE MOUSE
GROSSET, J
TRUFFOT, C
BOVAL, C
FERMANIAN, J
THORAX, 1979, 34 (05) : 708 - 708

← 1 2 3 4 5 →